Global A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H2 2016" report to their offering.

A disintegrin and metalloproteinase with thrombospondin motifs 5 or ADAMTS5 is an enzyme encoded by the ADAMTS5 gene. It plays an important role in the destruction of aggrecan in arthritic diseases and in proteolytic processing mostly during the peri-implantation period.

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies.The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1 and 2 respectively.

Our latest report A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Pipeline Review, H2 2016, outlays comprehensive information on the A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Key Topics Covered:

  1. Introduction
  2. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Overview
  3. Therapeutics Development
  4. Pipeline Products for A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Overview
  5. Pipeline Products for A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Comparative Analysis
  6. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Therapeutics under Development by Companies
  7. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Therapeutics under Investigation by Universities/Institutes
  8. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Products under Development by Companies
  13. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Products under Investigation by Universities/Institutes
  14. A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Companies Involved in Therapeutics Development
  • Asahi Kasei Pharma Corp.
  • GlaxoSmithKline Plc
  • Oscotec Inc.
  • Paradigm Biopharmaceuticals Limited

For more information about this report visit http://www.researchandmarkets.com/research/mrrsc8/a_disintegrin_and

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals